MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 689.61 Thousand CAD | 1.26% |
| 2022 | 681.02 Thousand CAD | -6.85% |
| 2021 | 731.06 Thousand CAD | -0.45% |
| 2020 | 734.39 Thousand CAD | 68.48% |
| 2019 | 435.89 Thousand CAD | -33.16% |
| 2018 | 652.16 Thousand CAD | -2.8% |
| 2017 | 670.97 Thousand CAD | -15.92% |
| 2016 | 798.06 Thousand CAD | 22.02% |
| 2015 | 654.04 Thousand CAD | 37.42% |
| 2014 | 475.94 Thousand CAD | -20.7% |
| 2013 | 600.2 Thousand CAD | 26.17% |
| 2012 | 475.7 Thousand CAD | -37.54% |
| 2011 | 761.58 Thousand CAD | 82.35% |
| 2010 | 417.65 Thousand CAD | 15.44% |
| 2009 | 361.79 Thousand CAD | -73.18% |
| 2008 | 1.34 Million CAD | 15.32% |
| 2007 | 1.16 Million CAD | -16.13% |
| 2006 | 1.39 Million CAD | -39.85% |
| 2005 | 2.31 Million CAD | 40.05% |
| 2004 | 1.65 Million CAD | 23.78% |
| 2003 | 1.33 Million CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 703.18 Thousand CAD | 1.97% |
| 2024 Q2 | 853.83 Thousand CAD | 21.42% |
| 2023 Q3 | 765.24 Thousand CAD | -6.36% |
| 2023 Q4 | 689.61 Thousand CAD | -9.88% |
| 2023 Q2 | 817.24 Thousand CAD | -36.56% |
| 2023 Q1 | 1.28 Million CAD | 89.17% |
| 2023 FY | 689.61 Thousand CAD | 1.26% |
| 2022 Q4 | 681.02 Thousand CAD | -9.86% |
| 2022 Q1 | 719.35 Thousand CAD | -1.6% |
| 2022 Q2 | 728.59 Thousand CAD | 1.28% |
| 2022 FY | 681.02 Thousand CAD | -6.85% |
| 2022 Q3 | 755.5 Thousand CAD | 3.69% |
| 2021 Q2 | 2.52 Million CAD | -13.42% |
| 2021 Q4 | 731.06 Thousand CAD | -48.15% |
| 2021 FY | 731.06 Thousand CAD | -0.45% |
| 2021 Q1 | 2.91 Million CAD | 296.5% |
| 2021 Q3 | 1.4 Million CAD | -44.08% |
| 2020 Q1 | 490.13 Thousand CAD | 12.44% |
| 2020 Q4 | 734.39 Thousand CAD | 6.48% |
| 2020 FY | 734.39 Thousand CAD | 68.48% |
| 2020 Q2 | 978.97 Thousand CAD | 99.74% |
| 2020 Q3 | 689.7 Thousand CAD | -29.55% |
| 2019 Q4 | 435.89 Thousand CAD | -14.2% |
| 2019 FY | 435.89 Thousand CAD | -33.16% |
| 2019 Q3 | 508.06 Thousand CAD | -20.63% |
| 2019 Q2 | 640.09 Thousand CAD | 9.44% |
| 2019 Q1 | 584.9 Thousand CAD | -10.31% |
| 2018 FY | 652.16 Thousand CAD | -2.8% |
| 2018 Q2 | 1.15 Million CAD | -28.87% |
| 2018 Q1 | 1.63 Million CAD | 142.98% |
| 2018 Q3 | 680.63 Thousand CAD | -41.31% |
| 2018 Q4 | 652.16 Thousand CAD | -4.18% |
| 2017 FY | 670.97 Thousand CAD | -15.92% |
| 2017 Q1 | 637.98 Thousand CAD | -20.06% |
| 2017 Q2 | 811.92 Thousand CAD | 27.26% |
| 2017 Q4 | 670.97 Thousand CAD | -2.15% |
| 2017 Q3 | 685.74 Thousand CAD | -15.54% |
| 2016 FY | 798.06 Thousand CAD | 22.02% |
| 2016 Q4 | 798.06 Thousand CAD | -30.62% |
| 2016 Q3 | 1.15 Million CAD | 73.75% |
| 2016 Q1 | 611 Thousand CAD | -6.58% |
| 2016 Q2 | 661.98 Thousand CAD | 8.34% |
| 2015 Q4 | 654.04 Thousand CAD | 47.62% |
| 2015 Q3 | 443.06 Thousand CAD | -55.48% |
| 2015 Q2 | 995.11 Thousand CAD | 147.48% |
| 2015 Q1 | 402.09 Thousand CAD | -15.52% |
| 2015 FY | 654.04 Thousand CAD | 37.42% |
| 2014 FY | 475.94 Thousand CAD | -20.7% |
| 2014 Q3 | 540.37 Thousand CAD | 4.54% |
| 2014 Q4 | 475.94 Thousand CAD | -11.92% |
| 2014 Q2 | 516.91 Thousand CAD | -20.26% |
| 2014 Q1 | 648.21 Thousand CAD | 8.0% |
| 2013 Q3 | 399.49 Thousand CAD | -14.79% |
| 2013 Q2 | 468.8 Thousand CAD | 12.95% |
| 2013 Q1 | 415.03 Thousand CAD | -12.75% |
| 2013 Q4 | 600.2 Thousand CAD | 50.24% |
| 2013 FY | 600.2 Thousand CAD | 26.17% |
| 2012 Q2 | 681.12 Thousand CAD | -1.48% |
| 2012 Q3 | 674.72 Thousand CAD | -0.94% |
| 2012 Q4 | 475.7 Thousand CAD | -29.5% |
| 2012 FY | 475.7 Thousand CAD | -37.54% |
| 2012 Q1 | 691.35 Thousand CAD | -9.22% |
| 2011 Q3 | 730.04 Thousand CAD | 16.04% |
| 2011 FY | 761.58 Thousand CAD | 82.35% |
| 2011 Q4 | 761.58 Thousand CAD | 4.32% |
| 2011 Q2 | 629.13 Thousand CAD | 62.58% |
| 2011 Q1 | 386.97 Thousand CAD | -7.35% |
| 2010 Q2 | 291.27 Thousand CAD | -6.75% |
| 2010 Q4 | 417.65 Thousand CAD | -7.6% |
| 2010 FY | 417.65 Thousand CAD | 15.44% |
| 2010 Q3 | 452.02 Thousand CAD | 55.19% |
| 2010 Q1 | 312.34 Thousand CAD | -13.67% |
| 2009 Q3 | 1.14 Million CAD | -4.7% |
| 2009 Q4 | 361.79 Thousand CAD | -68.39% |
| 2009 Q1 | 1.33 Million CAD | -1.26% |
| 2009 FY | 361.79 Thousand CAD | -73.18% |
| 2009 Q2 | 1.2 Million CAD | -9.83% |
| 2008 Q1 | 2.23 Million CAD | 90.84% |
| 2008 Q2 | 1.31 Million CAD | -41.29% |
| 2008 FY | 1.34 Million CAD | 15.32% |
| 2008 Q3 | 1.25 Million CAD | -4.23% |
| 2008 Q4 | 1.34 Million CAD | 7.48% |
| 2007 Q1 | 1.34 Million CAD | -3.76% |
| 2007 Q2 | 1.06 Million CAD | -20.61% |
| 2007 Q3 | 1.06 Million CAD | 0.03% |
| 2007 Q4 | 1.16 Million CAD | 9.73% |
| 2007 FY | 1.16 Million CAD | -16.13% |
| 2006 Q3 | 1.63 Million CAD | -6.33% |
| 2006 Q4 | 1.39 Million CAD | -14.58% |
| 2006 Q2 | 1.74 Million CAD | -22.68% |
| 2006 Q1 | 2.25 Million CAD | -2.76% |
| 2006 FY | 1.39 Million CAD | -39.85% |
| 2005 Q2 | 2.34 Million CAD | 22.8% |
| 2005 Q4 | 2.31 Million CAD | 2.54% |
| 2005 Q3 | 2.26 Million CAD | -3.57% |
| 2005 Q1 | 1.9 Million CAD | 15.34% |
| 2005 FY | 2.31 Million CAD | 40.05% |
| 2004 Q4 | 1.65 Million CAD | 0.0% |
| 2004 FY | 1.65 Million CAD | 23.78% |
| 2003 FY | 1.33 Million CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| IR-Med Inc. | 999 Thousand USD | 30.97% |
| BioElectronics Corporation | 144.38 Thousand USD | -377.612% |
| Medical Supply International USA, Inc. | 870.77 Thousand USD | 20.804% |
| CVR Medical Corp. | - USD | -Infinity% |
| Össur hf. | 1.39 Billion USD | 99.951% |
| Polarean Imaging plc | 10.86 Million USD | 93.654% |
| Avitar, Inc. | 1.74 Million USD | 60.544% |
| AVITA Medical, Inc. | 144.33 Million USD | 99.522% |
| Manhattan Scientifics, Inc. | 316 Thousand USD | -118.232% |
| Zecotek Photonics Inc. | 2.57 Million USD | 73.197% |
| QHSLab, Inc. | 1.68 Million USD | 58.987% |
| Wellstar International, Inc. | 957.89 Thousand USD | 28.007% |
| Össur hf. | 1.39 Billion USD | 99.951% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 102.92 Million USD | 99.33% |
| Escalon Medical Corp. | 4.75 Million USD | 85.506% |
| Aurora Spine Corporation | 11.92 Million USD | 94.216% |
| BrainsWay Ltd. | 62.97 Million USD | 98.905% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.85 Million USD | 75.829% |
| Hamilton Thorne Ltd. | 110.16 Million USD | 99.374% |
| Vivos Inc. | 1.61 Million USD | 57.17% |
| MicroPort Scientific Corporation | 3.93 Billion USD | 99.982% |
| Kelyniam Global, Inc. | 1.63 Million USD | 57.762% |
| REMSleep Holdings, Inc. | 1.2 Million USD | 42.833% |
| CYduct Diagnostics, Inc. | 54.74 Thousand USD | -1159.615% |
| Nanomix Corporation | 982.05 Thousand USD | 29.778% |
| Theraclion SA | 18.66 Million EUR | 96.305% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 182.18 Thousand USD | -278.534% |
| Positron Corporation | 1.76 Million USD | 60.987% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 748.38 Thousand USD | 7.853% |
| Lombard Medical, Inc. | 67.76 Million USD | 98.982% |
| ALR Technologies Inc. | 193.21 Thousand USD | -256.912% |
| Stratec SE | 529.71 Million USD | 99.87% |
| Vycor Medical, Inc. | 992.29 Thousand USD | 30.503% |
| Heart Tronics, Inc. | 4.04 Million USD | 82.968% |
| Nu-Med Plus, Inc. | 2.21 Million USD | 68.824% |
| Perimeter Medical Imaging AI, Inc. | 20.54 Million USD | 96.643% |
| SANUWAVE Health, Inc. | 22.41 Million USD | 96.924% |
| VMS Rehab Systems, Inc. | 4.45 USD | -15496843.82% |
| Guided Therapeutics, Inc. | 1.66 Million USD | 58.681% |
| Ingen Technologies, Inc. | 737.73 Thousand USD | 6.523% |
| Odyssey Group International, Inc. | 455.79 Thousand USD | -51.3% |
| United American Healthcare Corporation | 10.37 Million USD | 93.356% |
| ECGI Holdings, Inc. | 5.2 Million USD | 86.742% |
| Capital Group Holdings, Inc. | 33.79 Thousand USD | -1940.64% |
| ADM Tronics Unlimited, Inc. | 2.13 Million USD | 67.756% |
| Urologix, Inc. | 5.66 Million USD | 87.831% |
| Rapid Therapeutic Science Laboratories, Inc. | 2.25 Million USD | 69.413% |
| Nexeon MedSystems Inc. | 20.35 Million USD | 96.611% |
| SS Innovations International, Inc. | 25.47 Million USD | 97.293% |
| Qualis Innovations, Inc. | 2431.00 USD | -28267.503% |
| Smith & Nephew plc | 9.97 Billion USD | 99.993% |
| NIOX Group Plc | 116.47 Million USD | 99.408% |
| Fuse Medical, Inc. | 16.25 Million USD | 95.759% |
| Broncus Holding Corporation | 195.75 Million USD | 99.648% |
| Brain Scientific Inc. | 11.74 Million USD | 94.128% |
| Pressure BioSciences, Inc. | 1.04 Million USD | 34.302% |
| Health Logic Interactive Inc. | 28.73 Thousand USD | -2299.91% |